| # | Drug | Count |
|---|---|---|
| 0 | CYTARABINE | 21 |
| 1 | METHOTREXATE | 12 |
| 2 | METHOTREXATE SODIUM | 12 |
| 3 | CYCLOPHOSPHAMIDE | 11 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 11 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 11 |
| 6 | DEXAMETHASONE | 9 |
| 7 | DEXAMETHASONE 1.5 MG | 9 |
| 8 | ALLOPURINOL | 8 |
| 9 | ATORVASTATIN CALCIUM | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | URINARY PAIN RELIEF | 1 | 0.0021 |
| 1 | CANDIDA ALBICANS, WOOD CREOSOTE, SODIUM CHLORIDE, AND SULFUR | 1 | 0.0021 |
| 2 | HYDROCODONE BITARTRATE AND IBUPROFEN | 1 | 0.0021 |
| 3 | TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE | 1 | 0.0021 |
| 4 | GEMTUZUMAB OZOGAMICIN | 6 | 0.0016 |
| 5 | AMIFOSTINE | 1 | 0.0012 |
| 6 | CHLOROTHIAZIDE SODIUM | 1 | 0.0011 |
| 7 | PENTOSTATIN | 1 | 0.0010 |
| 8 | CLOFARABINE | 2 | 0.0009 |
| 9 | CHLOROTHIAZIDE | 1 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nucleoside Metabolic Inhibitor [EPC] | 27 |
| 1 | Corticosteroid [EPC] | 21 |
| 2 | Alkylating Drug [EPC] | 16 |
| 3 | Platinum-based Drug [EPC] | 13 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 12 |
| 5 | Proton Pump Inhibitor [EPC] | 9 |
| 6 | Xanthine Oxidase Inhibitor [EPC] | 8 |
| 7 | Loop Diuretic [EPC] | 7 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 7 |
| 9 | Topoisomerase Inhibitor [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD33-directed Immunoconjugate [EPC] | 6 | 0.0016 |
| 1 | Non-Standardized Fungal Allergenic Extract [EPC] | 1 | 0.0005 |
| 2 | Photoenhancer [EPC] | 1 | 0.0003 |
| 3 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 27 | 0.0001 |
| 5 | Topoisomerase Inhibitor [EPC] | 7 | 0.0001 |
| 6 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 7 | Oxazolidinone Antibacterial [EPC] | 2 | 0.0001 |
| 8 | Alkylating Drug [EPC] | 16 | 0.0001 |
| 9 | Epidermal Growth Factor Receptor Antagonist [EPC] | 3 | 0.0001 |